From the 1Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
2Ministry of Health, Colombo, Sri Lanka
3Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia
4Environmental Interventions Unit, Infectious Diseases Division, Dhaka, Bangladesh.
Received September 21, 2022; revised and accepted November 06, 2022.
Funding/support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. C.H. is supported by Ministry of Health, Sri Lanka; F.S. holds a Monash University Graduate Research Scholarship; and S.R.D. is an NHMRC Senior Principal Research Fellow (grant number 1135843).
Financial disclosure/conflicts of interest: S.R.D. has been paid for developing and delivering educational presentations for Besins Healthcare, BioFemme, Biosyent, and Abbott; has been on Advisory Boards for Astellas Pharma, Theramex, Mayne Pharma, Gedeon Richter, and Roche Diagnostics; has been a consultant to Lawley Pharmaceuticals and Que Oncology; and has received institutional grant funding from Que Oncology and Ovocabio; there are no other relationships or activities that could appear to have influenced the submitted work.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s Website (www.menopause.org).
Address correspondence to: Rakibul M. Islam, MSS, MPhil, MPH, PhD, Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia. E-mail: [email protected]
